Pages that link to "Q45983340"
Jump to navigation
Jump to search
The following pages link to Partial remission with cyclosporine A in a patient with nephrotic syndrome due to NPHS2 mutation. (Q45983340):
Displaying 21 items.
- Nonimmunologic targets of immunosuppressive agents in podocytes (Q26781358) (← links)
- Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations (Q34013421) (← links)
- Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome (Q34405386) (← links)
- Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations (Q34746123) (← links)
- Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression (Q34787771) (← links)
- Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome (Q36543103) (← links)
- Actin-associated Proteins in the Pathogenesis of Podocyte Injury (Q37402598) (← links)
- Glomerular diseases: genetic causes and future therapeutics. (Q37774243) (← links)
- The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations. (Q37836591) (← links)
- The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient (Q38034908) (← links)
- Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. (Q38050959) (← links)
- Podocyte directed therapy of nephrotic syndrome-can we bring the inside out? (Q38458152) (← links)
- Podocytes from the diagnostic and therapeutic point of view (Q39309473) (← links)
- Management of severe idiopathic nephrotic syndrome in children (Q42952797) (← links)
- Non-immunologic mechanisms of calcineurin inhibitors explain its antiproteinuric effects in genetic glomerulopathies (Q44780024) (← links)
- Application of next-generation sequencing technology to diagnosis and treatment of focal segmental glomerulosclerosis. (Q52561530) (← links)
- Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. (Q52838570) (← links)
- Treatment of steroid-resistant nephrotic syndrome in the genomic era (Q57049336) (← links)
- Genetic diagnosis of steroid-resistant nephrotic syndrome in a longitudinal collection of Czech and Slovak patients: a high proportion of causative variants in NUP93 (Q59233759) (← links)
- Frasier syndrome: early gonadoblastoma and cyclosporine responsiveness (Q84110104) (← links)
- Current understandings in treating children with steroid-resistant nephrotic syndrome (Q89838674) (← links)